These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Cannabinoid hyperemesis syndrome: A review of the literature]. Desjardins N; Stheneur C Arch Pediatr; 2016 Jun; 23(6):619-23. PubMed ID: 27017363 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature. Burillo-Putze G; Richards JR; Rodríguez-Jiménez C; Sanchez-Agüera A Expert Opin Pharmacother; 2022 Apr; 23(6):693-702. PubMed ID: 35311429 [TBL] [Abstract][Full Text] [Related]
8. Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome. Venkatesan T; Levinthal DJ; Li BUK; Tarbell SE; Adams KA; Issenman RM; Sarosiek I; Jaradeh SS; Sharaf RN; Sultan S; Stave CD; Monte AA; Hasler WL Neurogastroenterol Motil; 2019 Jun; 31 Suppl 2(Suppl 2):e13606. PubMed ID: 31241817 [TBL] [Abstract][Full Text] [Related]
9. The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome. Lee C; Greene SL; Wong A Clin Toxicol (Phila); 2019 Sep; 57(9):773-777. PubMed ID: 30729854 [No Abstract] [Full Text] [Related]
10. Cannabinoid Hyperemesis Syndrome During Pregnancy: A Case Report. Andrews KH; Bracero LA J Reprod Med; 2015; 60(9-10):430-2. PubMed ID: 26592070 [TBL] [Abstract][Full Text] [Related]
11. Cannabis Hyperemesis Syndrome: A Still Under-Recognized Syndrome. Attout H; Amichi S; Josse F; Appavoupoule V; Randriajohany A; Thirapathi Y Eur J Case Rep Intern Med; 2020; 7(5):001588. PubMed ID: 32399447 [TBL] [Abstract][Full Text] [Related]
12. Cannabis hyperemesis syndrome: an update on the pathophysiology and management. Perisetti A; Gajendran M; Dasari CS; Bansal P; Aziz M; Inamdar S; Tharian B; Goyal H Ann Gastroenterol; 2020; 33(6):571-578. PubMed ID: 33162734 [TBL] [Abstract][Full Text] [Related]
13. Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review. Sorensen CJ; DeSanto K; Borgelt L; Phillips KT; Monte AA J Med Toxicol; 2017 Mar; 13(1):71-87. PubMed ID: 28000146 [TBL] [Abstract][Full Text] [Related]
15. Cannabinoid hyperemesis syndrome: a case series and review of previous reports. Nicolson SE; Denysenko L; Mulcare JL; Vito JP; Chabon B Psychosomatics; 2012; 53(3):212-9. PubMed ID: 22480624 [TBL] [Abstract][Full Text] [Related]
16. Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review. Khattar N; Routsolias JC Am J Ther; 2018; 25(3):e357-e361. PubMed ID: 28953512 [TBL] [Abstract][Full Text] [Related]
17. [High prevalence of cannabinoid hyperemesis syndrome in marijuana users]. Bruguera P; López-Pelayo H; Miquel L; Balcells-Oliveró M Emergencias; 2016 Ago; 28(4):249-251. PubMed ID: 29105413 [TBL] [Abstract][Full Text] [Related]
18. The cannabis hyperemesis syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana use: a report of eight cases in the United States. Soriano-Co M; Batke M; Cappell MS Dig Dis Sci; 2010 Nov; 55(11):3113-9. PubMed ID: 20130993 [TBL] [Abstract][Full Text] [Related]
19. Cannabinoid hyperemesis syndrome: a review of the literature. Deceuninck E; Jacques D Psychiatr Danub; 2019 Sep; 31(Suppl 3):390-394. PubMed ID: 31488758 [TBL] [Abstract][Full Text] [Related]
20. Cannabinoid hyperemesis syndrome: literature review and proposed diagnosis and treatment algorithm. Wallace EA; Andrews SE; Garmany CL; Jelley MJ South Med J; 2011 Sep; 104(9):659-64. PubMed ID: 21886087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]